Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Dysbiosis
DOI:
10.26508/lsa.202302529
Publication Date:
2024-02-05T19:00:10Z
AUTHORS (28)
ABSTRACT
Bidirectional interactions between the immune system and gut microbiota are key contributors to various physiological functions. Immune-associated diseases such as cancer autoimmunity, efficacy of immunomodulatory therapies, have been linked microbiome variation. Although COVID-19 infection has shown cause microbial dysbiosis, it remains understudied whether inflammatory response associated with vaccination also impacts microbiota. Here, we investigate temporal impact on in healthy immuno-compromised individuals; latter included patients primary immunodeficiency immunomodulating therapies. We find that remained remarkably stable post-vaccination irrespective diverse status, vaccine response, composition spanned by cohort. The stability is evident at all evaluated levels including diversity, phylum, species, functional capacity. Our results indicate resilience host changes triggered suggest minimal, if any, microbiome-mediated processes. These findings encourage acceptance, particularly when contrasted significant shifts observed during infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....